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Background
The purpose of this study was to compare the effects of a
pre-exercise drink (PRX1) called EM·PACT® to Gatorade®
(PRX2) on indices of aerobic performance. A previous
study had indicated that ingestion of PRX1 significantly
enhanced aerobic performance when compared to a water
placebo.
Methods
Twenty-two males (n = 13) and females (n = 9) ages 20–
36 years (23.68 +/- 3.91), volunteered as subjects. Each
subject performed two VO2max treadmill tests within two
weeks of each other. Administration of the trials was dou-
ble-blinded and randomized with half of the participants
ingesting PRX1 during the first trial and PRX2 during their
second trial with the product order being reversed for the
other subjects performing both exercise trials. In this
crossover design, each subject ingested the PRX1 or PRX2
exactly 20 minutes before each exercise bout. VO2max,
maximal heart rate (HR), time to exhaustion (Time), res-
piratory exchange ratio (RER), and fat substrate utilization
(%), during graded exercise testing were evaluated.
Results
Using repeated measures ANOVA, results indicated signif-
icant mean differences in VO2max  (ml.kg-1.min-1)
between PRX1 (50.65 +/- 8.27) and PRX2 (49.18 +/- 8.15)
trials for the total group (p = 0.036), but not among gen-
der (p > .05). No significant mean differences in maximal
Time (minutes) to exhaustion or HR (beats.min-1) were
found between the PRX1 (11.65 +/- 1.57; 186.41 +/- 9.03)
and PRX2 (11.54 +/- 1.65; 185.36 +/- 11.03) trials respec-
tively for all subjects as well as for gender (p > .05). Signif-
icant mean differences in maximal RER were found
between the PRX1 (1.19 +/- .071) and PRX2 (1.21 +/-
0.053) trials for all subjects (p = 0.026), but not for gender
(p > 0.05). Significant mean differences in percent fat sub-
strate utilization were found between PRX1 (61.06 +/-
22.05) and PRX2 (54.62 +/- 22.14) in stage 1 (3 minutes)
and in stage 2 (6 minutes), PRX1 (31.20 +/-17.89) and
PRX2 (22.78 +/- 16.88) for all subjects (p < 0.05), but not
for gender (p > 0.05) in the treadmill protocol used for
this study.
Conclusion
Differences in overall time to exhaustion as well as gender
specific values for each variable were not significantly dif-
ferent between the two exercise trials, however; during
aerobic exercise bouts, the combined results of this inves-
tigation may provide meaningful practical applications
for coaches and athletes alike regarding ergogenic hydra-
tion options.
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